Connect your AI

AbCellera Biologics Inc. ABCL Total Assets

Total Assets at other companies

Twist Bioscience CorporationTWST

$676.21M+13.5%

Recursion Pharmaceuticals, Inc.RXRX

$1.34B+2.6%

AnaptysBio, Inc.ANAB

$329.68M-21.9%

ZymeworksZYME

$478.22M+12.4%

PrecigenPGEN

$138.63M+7.6%

ADMA BiologicsADMA

$665.18M+30.3%

Other financials

Income statement

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Cash flow

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

Market cap$1.72B+59.2%

Enterprise value$1.76B+100.0%

P/S21.7×-25.0×

Profitability

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AbCellera Biologics Inc.'s total assets?: AbCellera Biologics Inc. (ABCL) reported total assets of $1.31B in Q1 2026.
How has AbCellera Biologics Inc.'s total assets changed year-over-year?: AbCellera Biologics Inc.'s total assets decreased by 2.8% year-over-year, from $1.34B to $1.31B.
What is the long-term trend for AbCellera Biologics Inc.'s total assets?: Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total assets has grown at a 6.2% compound annual growth rate (CAGR), from $1.01B to $1.36B.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.